Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2021
Mar. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (34,035) $ (26,063)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 3,284 2,194
Common stock issued for services 6,084 5,108
Amortization of debt discount 4,405 2,333
Amortization of operating lease right of use asset 168 91
Non cash interest payments 609 731
Change in fair value of derivative liabilities (744) (396)
Change in fair value of contingent real estate liability (446)
Changes in operating assets and liabilities:    
Accounts receivable (1,270) (407)
Inventory (1,310) 18
Other current assets (164) 477
Other assets (188)
Accounts payable and accrued expenses 961 195
Lease liabilities (170) (85)
Deferred revenue 123 (5)
Net Cash Used in Operating Activities (22,059) (16,443)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Cash paid for machinery and equipment (9,884) (6,340)
Cash received from sale of fixed assets 28
Cash paid for intangibles (50) (143)
Net Cash Used in Investing Activities (9,934) (6,455)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of common stock 75,394 32,189
Proceeds from exercise of employee stock options 1,270 64
Proceeds from exercise of warrants 1,109
Proceeds from employee stock purchase plan 204 168
Net Cash Provided by Financing Activities 77,977 32,421
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash 45,984 9,523
Cash, Cash Equivalents and Restricted Cash - Beginning of Period 44,408 30,154
Cash, Cash Equivalents and Restricted Cash - End of Period 90,392 39,677
Cash Paid During the Period for:    
Interest 325 488
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Common stock issued in note conversion (25,270)
Stock compensation payable 303
Fixed assets included in accounts payable and accrued expenses (1,467) 290
Stock issuance costs included in accounts payable and accrued expenses (230)
Reclass from assets held for sale (251)
Assets purchased using common stock $ 40